Brief: XORTX Files IND With FDA
March 31 (Reuters) - XORTX Therapeutics Inc XRTX.V :
* XORTX FILES IND WITH U.S. FDA
* XORTX - IND FILING IN SUPPORT OF XRX-008 PROGRAM FOR
TREATMENT
OF PROGRESSING KIDNEY DISEASE DUE TO AUTOSOMAL DOMINANT
POLYCYSTIC KIDNEY DISEASE
Source text for Eikon: ID:nGNX6TqGgf
Further company coverage: XRTX.V
((Reuters.Briefs@thomsonreuters.com;))
Recent news on XORTX Therapeutics
See all newsBrief: Xortx Outlines Anticipated Health Canada Clinical Trial Application For Xrx-026 For Gout
Brief: XORTX Therapeutics Announces Initiation Of Drug And Tablet Manufacturing For XRx-026 Program
Brief: Xortx Announces Termination And Postponement Of Investor Relations Program
Brief: XORTX Announces Director Resignation
Brief: Xortx Announces Us$5 Million Public Offering